CCSS Sends Letter of Support for Dietary Supplement Listing Act of 2022
On May 18, the Collaborative for Cannabinoid Science and Safety (CCSS) sent a letter to…
On May 18, the Collaborative for Cannabinoid Science and Safety (CCSS) sent a letter to…
On May 4, 2022, Johnson & Johnson filed a complaint in the United States District…
On May 15, 2022, Aimed Alliance updated its Copay Accumulator 101 Hub to include a…
On May 10, 2022, Aimed Alliance launched two new maps to track active and enacted…
When addressing the Food and Drug Administration’s (FDA) reluctancy to develop new regulations for cannabidiol…
Some patients that have recovered from a COVID-19 infection experience what the CDC has termed…
On May 11, 2022, Aimed Alliance’s staff attorney, Ashira Vantrees, participated as a panelist on…
In its 2023 Notice of Benefit and Payment Parameters Proposed Rule (2023 NBPP), the U.S.…
On April 13, the Food and Drug Administration published a draft guidance on “Diversity Plans…
On April 14, 2022, Michigan joined a growing number of states that can now offer…